(Q43040284)

12 November 2017

Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response (English)

1 reference

12 November 2017

0 references

1 reference

18

Naoya Sakamoto

1 reference

12 November 2017

19

Namiki Izumi

1 reference

12 November 2017

Yasuhiro Asahina

1

1 reference

12 November 2017

Kaoru Tsuchiya

2

1 reference

12 November 2017

Masaru Muraoka

3

1 reference

12 November 2017

Keisuke Tanaka

4

1 reference

12 November 2017

Yuichiro Suzuki

5

1 reference

12 November 2017

Nobuharu Tamaki

6

1 reference

12 November 2017

Yoshihide Hoshioka

7

1 reference

12 November 2017

Yutaka Yasui

8

1 reference

12 November 2017

Tomoji Katoh

9

1 reference

12 November 2017

Takanori Hosokawa

10

1 reference

12 November 2017

Ken Ueda

11

1 reference

12 November 2017

Hiroyuki Nakanishi

12

1 reference

12 November 2017

Jun Itakura

13

1 reference

12 November 2017

Yuka Takahashi

14

1 reference

12 November 2017

Masayuki Kurosaki

15

1 reference

12 November 2017

Nobuyuki Enomoto

16

1 reference

12 November 2017

Sayuri Nitta

17

1 reference

12 November 2017

language of work or name

English

0 references

publication date

29 November 2011

1 reference

12 November 2017

1 reference

12 November 2017

55

1 reference

12 November 2017

1

1 reference

12 November 2017

20-29

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

12 November 2017

1 reference

International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Initial and innate responses to viral infections--pattern setting in immunity or disease

21 January 2018

1 reference

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

21 January 2018

1 reference

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

21 January 2018

1 reference

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

21 January 2018

1 reference

VISA is an adapter protein required for virus-triggered IFN-beta signaling

21 January 2018

1 reference

The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I.

21 January 2018

1 reference

Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125

21 January 2018

1 reference

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

21 January 2018

1 reference

Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18)

21 January 2018

1 reference

UBP43 (USP18) specifically removes ISG15 from conjugated proteins

21 January 2018

1 reference

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

21 January 2018

1 reference

Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response

21 January 2018

1 reference

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha

21 January 2018

1 reference

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.24623

1 reference

12 November 2017

1 reference